Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Biofermin Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Series Intrinsic Opportunities Fund
100,000
0.82%
0
0.02%
04/30/2018
Fidelity Northstar Fund
75,000
0.62%
0
0.03%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
53,600
0.44%
800
0%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
26,300
0.22%
3,200
0%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
24,200
0.2%
0
0%
08/20/2018
DFA Japanese Small Company Series
22,500
0.19%
1,500
0.01%
01/31/2018
17,600
0.14%
4,500
0.18%
06/29/2018
14,397
0.12%
99
0.02%
07/31/2018
Mitsubishi UFJ MAXIS TOPIX ETF (1348)
7,000
0.06%
200
0%
07/31/2018
Aspiriant Risk Managed Global Equity Fund
3,600
0.03%
800
0.01%
02/28/2018

About Biofermin Pharmaceutical Co.

View Profile
Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.